Latest filing published 20 Apr 2010 for Dynavax Technologies CORP.
Insider track record
No signal scores available.
Symphony Capital Partners LP: trading record in brief
This profile gathers the share dealings of Symphony Capital Partners LP across 2 companies, led by Oncotelic Therapeutics, Inc. and Dynavax Technologies Corp. The record holds 3 filings, for trades running from 30 December 2008 to 16 April 2010.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 20 April 2010 with a transaction in Dynavax Technologies Corp. Filings reach the SEC (Form 4) feed a median of 23 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Symphony Capital Partners LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 690,631 sharesCommon Stock, par value $0.001 per shareSEC:0000950142-10-000687:0
- 10,000,000 sharesCommon Stock, par value .01 per shareSEC:0000950142-09-001110:0
- 11,281,877 shares@ US$1.11Common StockSEC:0000950142-09-001108:0
3 of 3 declarations
